Health Condition 1: I259- Chronic ischemic heart disease, unspecified
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Meenakshi Super Specialty Hospital
Eligibility
Inclusion criteria
Inclusion criteria: All the Patients who have been treated with Sirolimus Eluting Coronary Balloon had completed minimum 6-month follow-up. Participant is willing to undergo all study-related follow-up requirements.
Exclusion criteria
Exclusion criteria: All the Patients who have not been treated with Sirolimus Eluting Coronary Balloon System had not completed minimum 6-month follow-up. Participant is not willing to undergo all study-related follow-up requirements
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Major Adverse Cardiac Events 2. Quality of Life questionnaire 3. Adverse Events or Serious adverse eventsTimepoint: 1. Time Frame: Baseline, post-procedure, Through 6 months, 12 months ± 15 days 2.Time Frame: Through 6 months, 12 months ± 15 days 3. Time Frame: Baseline, post-procedure, Through 6 months, 12 months ± 15 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. All Mortality rate 2. Procedural Success and Device SuccessTimepoint: 1. Time Frame: Baseline, post-procedure, Through 6 months, 12 months ± 15 days 2. Time frame: Post-procedure and Intra-operative | — |
Countries
India
Contacts
Public ContactDr Sivakumar Rathnavel
Meenakshi Super Specialty Hospital
Outcome results
None listed